Welcome!

News Feed Item

China Interventional Cardiology Market Outlook to 2020

NEW YORK, Aug. 4, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Interventional Cardiology Market Outlook to 2020

http://www.reportlinker.com/p02127373/China-Interventional-Cardiology-Market-Outlook-to-2020.html

China Interventional Cardiology Market Outlook to 2020

Summary

GlobalData's new report, "China Interventional Cardiology Market Outlook to 2020", provides key market data on the China Interventional Cardiology market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Interventional Cardiology market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Interventional Cardiology categories - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Coronary Drug Eluting Balloons (DEB).
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the China Interventional Cardiology market.
- Key players covered include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Inc. and Cordis Corporation.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Interventional Cardiology Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Interventional Cardiology Market, China 10
3.1 Interventional Cardiology Market, China, Revenue ($m), 2005-2012 10
3.2 Interventional Cardiology Market, China, Revenue ($m), 2012-2020 12
3.2.1 Arteriotomy Closure Devices Market, China, Revenue ($m), by Segment, 2005-2012 14
3.2.2 Cardiac Catheters Market, China, Revenue ($m), by Segment, 2005-2012 16
3.2.3 Coronary Stents Market, China, Revenue ($m), by Segment, 2005-2012 18
3.2.4 Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), by Segment, 2005-2012 20
3.2.5 PTCA Balloons Market, China, Revenue ($m), by Segment, 2005-2012 22
3.2.6 Arteriotomy Closure Devices Market, China, Revenue ($m), by Segment, 2012-2020 24
3.2.7 Cardiac Catheters Market, China, Revenue ($m), by Segment, 2012-2020 26
3.2.8 Coronary Stents Market, China, Revenue ($m), by Segment, 2012-2020 28
3.2.9 Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), by Segment, 2012-2020 30
3.2.10 PTCA Balloons Market, China, Revenue ($m), by Segment, 2012-2020 32
3.3 Interventional Cardiology Market, China, Volume (Units), 2005-2012 34
3.4 Interventional Cardiology Market, China, Volume (Units), 2012-2020 36
3.4.1 Arteriotomy Closure Devices Market, China, Volume (Units), by Segment, 2005-2012 38
3.4.2 Cardiac Catheters Market, China, Volume (Units), by Segment, 2005-2012 40
3.4.3 Coronary Stents Market, China, Volume (Units), by Segment, 2005-2012 42
3.4.4 Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), by Segment, 2005-2012 44
3.4.5 PTCA Balloons Market, China, Volume (Units), by Segment, 2005-2012 46
3.4.6 Arteriotomy Closure Devices Market, China, Volume (Units), by Segment, 2012-2020 48
3.4.7 Cardiac Catheters Market, China, Volume (Units), by Segment, 2012-2020 50
3.4.8 Coronary Stents Market, China, Volume (Units), by Segment, 2012-2020 52
3.4.9 Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), by Segment, 2012-2020 54
3.4.10 PTCA Balloons Market, China, Volume (Units), by Segment, 2012-2020 56
3.5 Interventional Cardiology Market, China, Average Price ($), 2005-2020 58
3.6 Interventional Cardiology Market, China, Distribution Share by Revenue ($m), 2011-2012 60
3.7 Interventional Cardiology Market, China, Company Share by Revenue ($m), 2011-2012 61
4 Overview of Key Companies in China, Interventional Cardiology Market 63
4.1 Lepu Medical Technology (Beijing) Co., Ltd. 63
4.1.1 Company Overview 63
4.2 Terumo Corporation 63
4.2.1 Company Overview 63
4.3 Biosensors International Group, Ltd. 63
4.3.1 Company Overview 63
4.4 Abbott Laboratories 64
4.4.1 Company Overview 64
4.5 Boston Scientific Corporation 64
4.5.1 Company Overview 64
4.6 Medtronic, Inc. 64
4.6.1 Company Overview 64
4.7 Asahi Intecc Co., Ltd. 65
4.7.1 Company Overview 65
4.8 Volcano Corporation 65
4.8.1 Company Overview 65
4.9 Cordis Corporation 65
4.9.1 Company Overview 65
5 Interventional Cardiology Market Pipeline Products 66
6 Financial Deals Landscape 67
6.1 Partnerships 67
6.1.1 Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 67
6.1.2 Coherex Medical Enters Into Distribution Agreement With Biosense Webster 68
7 Appendix 69
7.1 Research Methodology 70
7.1.1 Coverage 70
7.1.2 Secondary Research 70
7.1.3 Primary Research 71
7.1.4 Market Modeling and Forecasting 72
7.1.5 Company Share Analysis 75
7.1.6 Distribution Share Analysis 76
7.2 Expert Panel 76
7.3 GlobalData Consulting 77
7.4 Contact Us 77
7.5 Disclaimer 77


1.1
List of Tables


Table 1: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 11
Table 2: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Table 3: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 15
Table 4: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 17
Table 5: Coronary Stents Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 19
Table 6: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 21
Table 7: PTCA Balloons Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 23
Table 8: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 25
Table 9: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 27
Table 10: Coronary Stents Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 29
Table 11: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 31
Table 12: PTCA Balloons Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 33
Table 13: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 35
Table 14: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 37
Table 15: Arteriotomy Closure Devices Market, China, Volume (Units), Historic, 2005-2012 39
Table 16: Cardiac Catheters Market, China, Volume (Units), Historic, 2005-2012 41
Table 17: Coronary Stents Market, China, Volume (Units), Historic, 2005-2012 43
Table 18: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Historic, 2005-2012 45
Table 19: PTCA Balloons Market, China, Volume (Units), Historic, 2005-2012 47
Table 20: Arteriotomy Closure Devices Market, China, Volume (Units), Forecast, 2012-2020 49
Table 21: Cardiac Catheters Market, China, Volume (Units), Forecast, 2012-2020 51
Table 22: Coronary Stents Market, China, Volume (Units), Forecast, 2012-2020 53
Table 23: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Forecast, 2012-2020 55
Table 24: PTCA Balloons Market, China, Volume (Units), Forecast, 2012-2020 57
Table 25: Interventional Cardiology Market, China, Average Price ($), Historic, 2005-2012 58
Table 26: Interventional Cardiology Market, China, Average Price ($), Forecast, 2012-2020 59
Table 27: Interventional Cardiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012 60
Table 28: Interventional Cardiology Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012 62
Table 29: Interventional Cardiology Market Pipeline Products 66
Table 30: Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 67
Table 31: Coherex Medical Enters Into Distribution Agreement With Biosense Webster 68
Table 32: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 72


1.2
List of Figures


Figure 1: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 10
Figure 2: Interventional Cardiology Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 12
Figure 3: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 14
Figure 4: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 16
Figure 5: Coronary Stents Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 18
Figure 6: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 20
Figure 7: PTCA Balloons Market, China, Revenue ($m), USD Constant, Historic, 2005-2012 22
Figure 8: Arteriotomy Closure Devices Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 24
Figure 9: Cardiac Catheters Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 26
Figure 10: Coronary Stents Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 28
Figure 11: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 30
Figure 12: PTCA Balloons Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020 32
Figure 13: Interventional Cardiology Market, China, Volume (Units), Historic, 2005-2012 34
Figure 14: Interventional Cardiology Market, China, Volume (Units), Forecast, 2012-2020 36
Figure 15: Arteriotomy Closure Devices Market, China, Volume (Units), Historic, 2005-2012 38
Figure 16: Cardiac Catheters Market, China, Volume (Units), Historic, 2005-2012 40
Figure 17: Coronary Stents Market, China, Volume (Units), Historic, 2005-2012 42
Figure 18: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Historic, 2005-2012 44
Figure 19: PTCA Balloons Market, China, Volume (Units), Historic, 2005-2012 46
Figure 20: Arteriotomy Closure Devices Market, China, Volume (Units), Forecast, 2012-2020 48
Figure 21: Cardiac Catheters Market, China, Volume (Units), Forecast, 2012-2020 50
Figure 22: Coronary Stents Market, China, Volume (Units), Forecast, 2012-2020 52
Figure 23: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), Forecast, 2012-2020 54
Figure 24: PTCA Balloons Market, China, Volume (Units), Forecast, 2012-2020 56
Figure 25: Interventional Cardiology Market, China, Company Share (%), 2012 61
Figure 26: GlobalData Epidemiology-Based Forecasting Model 74
Figure 27: GlobalData Capital Equipment-Based Forecasting Model 75
Figure 28: Primary Interviews by Participant Type (%) 76


To order this report: China Interventional Cardiology Market Outlook to 2020
http://www.reportlinker.com/p02127373/China-Interventional-Cardiology-Market-Outlook-to-2020.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, discussed how given the magnitude of today's application ...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
The “Digital Era” is forcing us to engage with new methods to build, operate and maintain applications. This transformation also implies an evolution to more and more intelligent applications to better engage with the customers, while creating significant market differentiators. In both cases, the cloud has become a key enabler to embrace this digital revolution. So, moving to the cloud is no longer the question; the new questions are HOW and WHEN. To make this equation even more complex, most ...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: imple...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...